CTSS and lupus nephritis: In addition, treatment with a CTSS inhibitor decreases the severity of lupus nephritis in animals by inhibiting CTSS activity and antigen presenting cell activity to attenuate the MHC II-related lymphocyte responses (24) and CTSS knockout decreases the risk for development of diabetic nephropathy by reducing microvascular complications (25, 26).